Publication:
A structurationist analysis of differing policies oriented to the pharmaceutical industry: Turkey and Brazil

dc.contributor.authorsYaşgül Y.S.
dc.date.accessioned2022-03-15T02:10:11Z
dc.date.accessioned2026-01-10T16:53:28Z
dc.date.available2022-03-15T02:10:11Z
dc.date.issued2014
dc.description.abstractThis chapter has two purposes closely related to each other. The first one is to analyze why countries that have similar characteristics and benefits to each other develop different strategies in terms of rules that regulate the intellectual property rights in the pharmaceutical industry. The second one is to analyze the factors that determine active participation in global governance processes with regards to the intellectual property rights of countries that are developing, specifically in the pharmaceutical industry. The study used the structurationist approach developed by John M. Hobson, and findings were tested by comparing the examples of two countries: Turkey and Brazil. © 2014 by IGI Global. All rights reserved.
dc.identifier.doi10.4018/978-1-4666-6224-7.ch016
dc.identifier.isbn9781466662254; 1466662247; 9781466662247
dc.identifier.urihttps://hdl.handle.net/11424/247433
dc.language.isoeng
dc.publisherIGI Global
dc.relation.ispartofHandbook of Research on Economic Growth and Technological Change in Latin America
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleA structurationist analysis of differing policies oriented to the pharmaceutical industry: Turkey and Brazil
dc.typebookPart
dspace.entity.typePublication
oaire.citation.endPage312
oaire.citation.startPage291
oaire.citation.titleHandbook of Research on Economic Growth and Technological Change in Latin America

Files